Condition 101 About Apolipoprotein C2 Deficiency

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Apolipoprotein C2 Deficiency

View All Doctors

Latest Advances On Apolipoprotein C2 Deficiency

  • Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • Published —
THE PREVALENCE OF PROBABLE FAMILIAL CHYLOMICRONEMIA SYNDROME IN A SOUTHERN CALIFORNIA POPULATION.
  • Condition: Familial Chylomicronemia Syndrome (FCS) or Hypertriglyceridemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Volanesorsen
  • Number of Patients: 0
  • Published —
This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
View All Latest Advances

Clinical Trials For Apolipoprotein C2 Deficiency

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 120
  • Start Date: July 7, 2021
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Evinacumab in Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: November 18, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)
View All Clinical Trials